查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年胃滞留给药系统市场预测：按类型、剂型、配销通路和地区分類的全球分析
市场调查报告书
商品编码
1371994

2030 年胃滞留给药系统市场预测：按类型、剂型、配销通路和地区分類的全球分析

Gastro-retentive Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Type, Dosage Form, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球胃滞留给药系统市场规模为 149 亿美元，预测期内年复合成长率为 12.1%，到 2030 年将达到 331 亿美元。

「胃滞留药物递送」指用于将药物化合物递送至胃肠道内目标部位的方法、製剂、製造技术、储存系统和技术，并决定药物递送系统的功效和安全性。应用製造、给药途径、位点特异性标靶、代谢和毒性来提高药物生产。透过胃滞留给药方法加强黏膜保护可用于预防和控制病理。

根据亚利桑那大学发表的论文，新兴国家的幽门螺旋桿菌病菌感染高于已开发国家。在开发中国家% 。

胃药需求不断成长

主要製药公司配合措施改善胃滞留药物传输系统，以及由于生物利用度提高而增加的药物需求和减少的给药，推动了市场成长。此外，胃滞留药物输送系统在治疗各种类型的胃病（包括消化性溃疡和胃溃疡）方面的功效已得到证实，而导致胃炎和胃癌的幽门螺旋桿菌病菌感染的患病正在增加。使胃滞留药物得以使用，并对市场扩张产生了重大影响。

患者接受度下降

由于这些新的给药技术具有创新性，因此很难被患者接受。此外，传统的口服剂型可能是优选的，特别是对于吞嚥困难或喜欢较小剂型的患者。此外，确保一致的依从性也很困难，因为它依赖于患者遵循特定的给药指示。因此，有些患者发现胃滞留药物输送系统（GRDDS）的尺寸和特性较不方便，市场可能会大幅下降。

技术进步

胃滞留给药技术的使用已被证明是控制各种药物给药同时提高生物利用度的有效技术。此外，近年来，超越胃排空时间不规则和胃停留时间短等物理挑战的技术创新导致了受控口服给药系统的改进。此外，once-GRDDS可以透过延长在上胃肠道的停留时间来提高治疗效果和口服生物利用度。因此，这些进步是推动市场规模扩大的驱动力。

与配方相关的风险

在创造能够始终黏附在胃肠黏膜或漂浮在胃中同时以受控速率释放药物的药物製剂中，需要克服一些挑战。此外，实现黏度、浮力和控制释放之间的平衡需要精确的配方方法和彻底的研究。此外，需要确保药物在胃肠道环境中的稳定性进一步增加了难度。因此，这些困难往往会导致更长的开发时间和更高的价格，从而影响市场成长。

COVID-19 的影响

胃滞留给药系统 (GRDDS) 市场受到了 COVID-19 爆发的负面影响。当医疗保健系统专注于对抗病毒时，基于 GRDDS 的药物开发的临床试验和研究被推迟。此外，进入医疗保健设施受到限制，影响了临床试验的患者招募和创新药物输送方法的引入。此外，经济限制和供应链中断阻碍了 GRDDS 产品的生产和分销。因此，由于疫情导致医疗保健系统的财政负担日益增加，《新药交付法案》的预算受到影响，逐渐阻碍了市场的成长。

浮动药物传输系统（FDDS）领域预计将在预测期内达到最大的领域

预计浮动给药系统领域将占最大份额。这些药物製剂会长时间悬浮在胃中。此外，这些方法允许药物在胃液中漂浮的同时逐渐释放，改善药物吸收并延长治疗效果。漂浮药物输送系统（FDDS）可以减少副作用、减少给药频率并增加药物吸收。此外，它对吸收窗较小的药物特别有效，用于治疗多种胃肠道疾病。因此，FDDS作为一种最先进的改善药物传递的方法，可以提高患者的依从性并确保胃肠滞留药物的治疗效果，从而扩大市场规模。

预计微球细分市场在预测期内年复合成长率最高

由于在药物配方中使用小球形颗粒来改善药物在胃肠道的吸收，因此预计微球细分市场在预测期内将出现最高的年复合成长率。此外，这些微球可以含有控制释放的药物，并且通常由生物相容性材料製成。这些提供了消费后的好处，例如更长的给药、更少的给药和更少的副作用。使用微球的GRDDS已用于治疗各种胃肠道疾病，提高了患者的依从性和治疗效果。因此，本节提出了独特的药理学策略，以增强消化器官系统药物吸收和治疗效果，从而显着推动市场。

比最大的地区

由于其优异的药物吸收和患者依从性，亚太地区在预测期内占据了最大的市场占有率。此外，亚太地区还在医学研究和基础设施开发上投入资金，这正在推动创新和市场成长。法规变化和慢性病的增加进一步加速了 GRDDS 的采用。因此，GRDDS 行业的药房、研究人员和医疗保健专业人员在该地区有很多机会。

复合年复合成长率最高的地区：

欧洲在 GRDDS 技术的进步中发挥着重要作用，预计在预测期内将表现出最高的年复合成长率，因为它同时注重创新和优质医疗保健。此外，该地区高龄化和胃肠道疾病的高患病需要更好的给药方法。此外，欧洲医疗保健系统正在鼓励 GRDDS 的开发和部署，以改善治疗结果、患者依从性和生活品质。因此，严格的法规标准确保了产品安全和充满活力的市场。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球胃滞留给药系统市场：依类型

  • 可扩展的药物传输系统
  • 黏合药物传输系统
  • 漂浮给药系统 (FDDS)
  • 高密度系统
  • 其他类型

第6章全球胃滞留给药系统市场：按剂型

  • 微球
  • 药片
  • 胶囊
  • 其他剂型

第7章全球胃滞留给药系统市场：按配销通路

  • 网路药房
  • 医院药房
  • 零售药房
  • 其他配销通路

第8章全球胃滞留给药系统市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Ranbaxy
  • GlaxoSmithKline
  • Competition Deep Dive
  • Depomed
  • Pharmacia
  • Alcon, Inc.
  • Lupin
  • Galanix
  • Sun Pharma
  • F. Hoffmann La Roche
Product Code: SMRC24050

According to Stratistics MRC, the Global Gastro-retentive Drug Delivery Systems Market is accounted for $14.9 billion in 2023 and is expected to reach $33.1 billion by 2030 growing at a CAGR of 12.1% during the forecast period. The term "gastro-retentive drug delivery" refers to methods, formulations, production techniques, storage systems, and technologies used to deliver pharmaceutical compounds to the target location in the gastro-intestinal tract, to enhance the effectiveness and safety of a drug delivery system, principles relating to drug manufacturing, route of administration, site-specific targeting, metabolism, and toxicity are applied. The enhancement of mucosal protection by the gastro-retentive drug delivery method can be used to prevent and control the condition.

According to the article published by the University of Arizona, H.pylori infection is higher in developing countries than the developed countries. The incidence of new infections in developing countries is 3 to 10% of the population compared to 0.5% in developed economies.

Market Dynamics:

Driver:

Rising demand for gastro-retentive drugs

The market's growth has been accelerated by large pharmaceutical companies' efforts to improve gastro-retentive drug delivery systems, together with dose reductions due to improved bioavailability and an increase in the demand for drugs. Additionally, the market is greatly influenced by the well-established effectiveness of gastro-retentive drug delivery systems in treating various kinds of stomach disorders, including peptic ulcer and gastric ulcer, as well as an increase in the prevalence of H.pylori infection, which can lead to gastritis and gastric cancer which enabled the use of gastro-retentive drugs resulting in market expansion.

Restraint:

Decrease in Patient acceptance

The innovative nature of these new medicine delivery techniques may make them difficult for patients to accept. Additionally, patients may prefer traditional oral dosage forms especially for individuals who have difficulty swallowing or who prefer smaller-sized dosage forms. Moreover, ensuring consistent compliance is also challenging, as it relies on patients following specific administration instructions. Thus, some patients may find the size or characteristics of Gastro-retentive Drug Delivery Systems (GRDDS) less convenient by which the market gets significantly retrain.

Opportunity:

Technological advancements

The use of gastro-retentive drug delivery technology has proven to be an effective technique to control the dosage of a variety of pharmaceuticals while increasing bioavailability. Moreover, technology innovations that go beyond physical challenges like erratic stomach emptying timings and brief gastric residency times have led to improvements in controlled oral medicine administration systems in recent years. Additionally, once-GRDDS can improve therapeutic effectiveness and oral bioavailability by prolonging their duration in the upper GI tract. Hence, these advancements drive the market size.

Threat:

Risks associated while formulating

There are challenging obstacles to overcome when creating pharmacological formulations that can consistently stick to the gastrointestinal mucosa or float in the stomach while releasing the drug at a controlled rate. Moreover, it takes exact formulation methods and in-depth research to achieve this balance of adhesion, buoyancy, and controlled release. Additionally, the difficulty is increased further by the need to ensure the drug's stability in the gastrointestinal environment. Therefore, these difficulties frequently lead to longer development times and higher prices, which have an effect on market growth.

COVID-19 Impact

The market for gastro-retentive drug delivery systems (GRDDS) has been negatively impacted by the COVID-19 epidemic. Clinical trials and research for the development of GRDDS-based drugs were delayed while healthcare systems concentrated on fighting the virus. Additionally, access to medical facilities became restricted, which had an impact on the recruitment of patients for clinical trials and the uptake of innovative drug delivery methods. Moreover, economical limitations and supply chain interruptions have hampered the manufacture and distribution of GRDDS goods. Therefore, budgets for novel drug delivery methods were impacted as a result of the pandemic's increasing financial load on healthcare systems which gradually hampered the market growth.

The floating drug delivery system (FDDS) segment is expected to be the largest during the forecast period

The floating drug delivery system segment is estimated to hold the largest share. These are drug formulations that remain buoyant in the stomach for an extended period. Additionally, these methods allow medications to release gradually while floating on the gastric fluid, improving drug absorption and extending therapeutic benefits. Floating drug delivery system (FDDS) can reduce side effects, decrease dosage frequency, and increase drug absorption. Furthermore, they are particularly helpful for medications with small absorption windows and are used in the treatment of a variety of gastrointestinal ailments. Therefore, a cutting-edge method for improving medication delivery, FDDS ensures higher patient compliance and therapeutic effectiveness in gastro-retentive medicines thereby increasing the market expansion.

The microspheres segment is expected to have the highest CAGR during the forecast period

The microspheres segment is anticipated to have highest CAGR during the forecast period due to the use of small, spherical particles in medicine formulations to improve absorption of the medicament in the gastrointestinal tract. Additionally, these microspheres can contain medications for controlled release and are typically made of biocompatible substances. They provide advantages after consumption, including longer drug administration, decreased dosage frequency, and reduced side effects. GRDDS with microspheres is used to treat a variety of gastrointestinal illnesses, enhancing patient compliance and therapeutic results. Hence, this section shows an original pharmacological strategy for enhancing gastrointestinal system drug absorption and therapeutic efficacy by significantly driving the market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to due to their better drug absorption and patient compliance. Additionally, the Asia-Pacific region is spending money on medical research and infrastructure, which encourages innovation and market growth. Adoption of GRDDS is further fuelled by regulatory changes and the rise in chronic diseases. Therefore, pharmacies, researchers, and healthcare practitioners in the GRDDS industry have a lot of opportunities in this region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a major role in the advancement of GRDDS technology, placing a strong emphasis on both innovation and high-quality healthcare. Additionally, there is a need for better drug delivery methods due to the aging population in the area and the high prevalence of gastrointestinal illnesses. Moreover, in order to improve treatment outcomes, patient compliance, and quality of life, European healthcare systems encourage the development and deployment of GRDDS. Hence, stringent regulatory standards ensure product safety, making it a thriving market.

Key players in the market:

Some of the key players in the Gastro-retentive Drug Delivery Systems Market include: Ranbaxy, GlaxoSmithKline, Competition Deep Dive, Depomed, Pharmacia, Alcon, Inc., Lupin, Galanix, Sun Pharma and F. Hoffmann La Roche.

Key Developments:

In October 2023, Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for deuruxolitinib, an investigational oral selective inhibitor of Janus kinases, for the treatment of adults with moderate to severe alopecia areata.

In March 2023, Sun Pharmaceutical Industries Limited announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company that is developing deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia area.

Types Covered:

  • Expandable Drug Delivery System
  • Bioadhesive Drug Delivery System
  • Floating Drug Delivery System
  • High Density System
  • Other Types

Dosage Forms Covered:

  • Microspheres
  • Tablets
  • Capsule
  • Other Dosage Forms

Distribution Channels Covered:

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gastro-retentive Drug Delivery Systems Market, By Type

  • 5.1 Introduction
  • 5.2 Expandable Drug Delivery System
  • 5.3 Bioadhesive Drug Delivery System
  • 5.4 Floating Drug Delivery System (FDDS)
  • 5.5 High Density System
  • 5.6 Other Types

6 Global Gastro-retentive Drug Delivery Systems Market, By Dosage Form

  • 6.1 Introduction
  • 6.2 Microspheres
  • 6.3 Tablets
  • 6.4 Capsule
  • 6.5 Other Dosage Forms

7 Global Gastro-retentive Drug Delivery Systems Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Pharmacies
  • 7.3 Hospital Pharmacies
  • 7.4 Retail Pharmacies
  • 7.5 Other Distribution Channels

8 Global Gastro-retentive Drug Delivery Systems Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Ranbaxy
  • 10.2 GlaxoSmithKline
  • 10.3 Competition Deep Dive
  • 10.4 Depomed
  • 10.5 Pharmacia
  • 10.6 Alcon, Inc.
  • 10.7 Lupin
  • 10.8 Galanix
  • 10.9 Sun Pharma
  • 10.10 F. Hoffmann La Roche

List of Tables

  • Table 1 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 4 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 5 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 6 Global Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 7 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 9 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 10 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 11 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 12 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 13 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 14 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 15 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 16 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 17 Global Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 18 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 21 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 22 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 23 North America Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 24 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 25 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 26 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 27 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 28 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 29 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 30 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 31 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 32 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 33 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 34 North America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 35 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 38 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 39 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 40 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 41 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 42 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 43 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 44 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 45 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 46 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 47 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 48 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 49 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 50 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 51 Europe Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 52 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 55 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 56 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 57 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 58 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 59 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 60 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 61 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 62 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 63 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 64 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 65 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 66 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 67 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 68 Asia Pacific Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 69 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 72 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 73 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 74 South America Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 75 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 76 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 77 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 78 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 79 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 80 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 81 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 82 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 83 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 84 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 85 South America Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 86 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Expandable Drug Delivery System (2021-2030) ($MN)
  • Table 89 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Bioadhesive Drug Delivery System (2021-2030) ($MN)
  • Table 90 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Floating Drug Delivery System (FDDS) (2021-2030) ($MN)
  • Table 91 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By High Density System (2021-2030) ($MN)
  • Table 92 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 93 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 94 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Microspheres (2021-2030) ($MN)
  • Table 95 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 96 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 97 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 98 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 99 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 100 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 101 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 102 Middle East & Africa Gastro-retentive Drug Delivery Systems Market Outlook, By Other Distribution Channels (2021-2030) ($MN)